209 related articles for article (PubMed ID: 37240366)
1. CRISPR-Mediated In Situ Introduction or Integration of
Tang Q; Hu Z; Zhao J; Zhou T; Tang S; Wang P; Xiao R; Chen Y; Wu L; Zhou M; Liang D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240366
[TBL] [Abstract][Full Text] [Related]
2. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
[TBL] [Abstract][Full Text] [Related]
4. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model.
Luce E; Steichen C; Allouche M; Messina A; Heslan JM; Lambert T; Weber A; Nguyen TH; Christophe O; Dubart-Kupperschmitt A
Hepatology; 2022 Apr; 75(4):866-880. PubMed ID: 34687060
[TBL] [Abstract][Full Text] [Related]
5. Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of
Wang Y; Zhao J; Duan N; Liu W; Zhang Y; Zhou M; Hu Z; Feng M; Liu X; Wu L; Li Z; Liang D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301136
[TBL] [Abstract][Full Text] [Related]
6. Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua.
Li B; Wu Z; Xu W; Han W; Liu J; Wang D; Zhang G
Hum Gene Ther; 2021 May; 32(9-10):506-516. PubMed ID: 33764159
[TBL] [Abstract][Full Text] [Related]
7. Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology.
Ma Y; Sun W; Zhao L; Yao M; Wu C; Su P; Yang L; Wang G
Stem Cell Res Ther; 2022 Jul; 13(1):353. PubMed ID: 35883203
[TBL] [Abstract][Full Text] [Related]
8. Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency).
Sekayan T; Simmons DH; von Drygalski A
Expert Opin Biol Ther; 2023; 23(12):1173-1184. PubMed ID: 37962325
[TBL] [Abstract][Full Text] [Related]
9. AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.
Crudele JM; Finn JD; Siner JI; Martin NB; Niemeyer GP; Zhou S; Mingozzi F; Lothrop CD; Arruda VR
Blood; 2015 Mar; 125(10):1553-61. PubMed ID: 25568350
[TBL] [Abstract][Full Text] [Related]
10. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.
Martorell L; Luce E; Vazquez JL; Richaud-Patin Y; Jimenez-Delgado S; Corrales I; Borras N; Casacuberta-Serra S; Weber A; Parra R; Altisent C; Follenzi A; Dubart-Kupperschmitt A; Raya A; Vidal F; Barquinero J
J Thromb Haemost; 2017 Nov; 15(11):2188-2197. PubMed ID: 28834196
[TBL] [Abstract][Full Text] [Related]
11. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
[TBL] [Abstract][Full Text] [Related]
12. Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration.
Chen X; Niu X; Liu Y; Zheng R; Yang L; Lu J; Yin S; Wei Y; Pan J; Sayed A; Ma X; Liu M; Jing F; Liu M; Hu J; Wang L; Li D
J Genet Genomics; 2022 Dec; 49(12):1114-1126. PubMed ID: 35691554
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia Gene Therapy: Ready for Prime Time?
VandenDriessche T; Chuah MK
Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
[TBL] [Abstract][Full Text] [Related]
14. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B.
Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L
Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
[TBL] [Abstract][Full Text] [Related]
16. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells.
Hiramoto T; Kashiwakura Y; Hayakawa M; Baatartsogt N; Kamoshita N; Abe T; Inaba H; Nishimasu H; Uosaki H; Hanazono Y; Nureki O; Ohmori T
Commun Med (Lond); 2023 Apr; 3(1):56. PubMed ID: 37076593
[TBL] [Abstract][Full Text] [Related]
17. BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
Konkle BA; Walsh CE; Escobar MA; Josephson NC; Young G; von Drygalski A; McPhee SWJ; Samulski RJ; Bilic I; de la Rosa M; Reipert BM; Rottensteiner H; Scheiflinger F; Chapin JC; Ewenstein B; Monahan PE
Blood; 2021 Feb; 137(6):763-774. PubMed ID: 33067633
[TBL] [Abstract][Full Text] [Related]
18. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.
Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F
Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235
[TBL] [Abstract][Full Text] [Related]
19. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.
Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS
Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.
Lu L; Wang L; Shen W; Fang S; Zhao L; Hu X; Yang L; Wang G
Mol Genet Genomic Med; 2023 May; 11(5):e2147. PubMed ID: 36795372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
